RegenXBio Financial Overview
RegenXBio's market cap is currently $666.71M. The company's EPS TTM is $-1.2; its P/E ratio is -3.87; RegenXBio is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.
